| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |